$5.04
+0.01 (+0.10%)
Open$5.02
Previous Close$5.04
Day High$5.11
Day Low$4.98
52W High$9.74
52W Low$2.59
Volume—
Avg Volume794.8K
Market Cap108.54M
P/E Ratio—
EPS$-0.75
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+910.3% upside
Current
$5.04
$5.04
Target
$50.92
$50.92
$37.48
$50.92 avg
$70.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 66.50M | 58.60M | 17.09M |
| Net Income | -19,928,709 | -15,805,285 | -4,142,594 |
| Profit Margin | -30.0% | -28.5% | -24.3% |
| EBITDA | -12,234,168 | -10,241,857 | -7,262,848 |
| Free Cash Flow | — | — | -5,494,601 |
| Rev Growth | +13.5% | +13.5% | +9.1% |
| Debt/Equity | 1.49 | 1.49 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |